| Therapeutic potential of cannabinoids in psychosis FM Leweke, JK Mueller, B Lange, C Rohleder Biological psychiatry 79 (7), 604-612, 2016 | 117 | 2016 |
| Cannabidiol as a potential new type of an antipsychotic. A critical review of the evidence C Rohleder, JK Müller, B Lange, FM Leweke Frontiers in Pharmacology 7, 422, 2016 | 110 | 2016 |
| Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders C Schaefer, F Enning, JK Mueller, JM Bumb, C Rohleder, TM Odorfer, ... European archives of psychiatry and clinical neuroscience 264 (5), 459-463, 2014 | 79 | 2014 |
| IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia EG Severance, KL Gressitt, A Alaedini, C Rohleder, F Enning, JM Bumb, ... Brain, behavior, and immunity 44, 148-158, 2015 | 67 | 2015 |
| How gender affects the pharmacotherapeutic approach to treating psychosis–a systematic review B Lange, JK Mueller, FM Leweke, JM Bumb Expert opinion on pharmacotherapy 18 (4), 351-362, 2017 | 58 | 2017 |
| Bipolar disorder: clinical overview. JK Müller, FM Leweke Medizinische Monatsschrift Fur Pharmazeuten 39 (9), 363-9, 2016 | 56 | 2016 |
| Role of the endocannabinoid system in the pathophysiology of schizophrenia: implications for pharmacological intervention FM Leweke, JK Mueller, B Lange, S Fritze, CE Topor, D Koethe, ... CNS drugs 32 (7), 605-619, 2018 | 51 | 2018 |
| Predominant expression of tryptophan hydroxylase 1 mRNA in the pituitary: a postmortem study in human brain P Zill, A Büttner, W Eisenmenger, J Müller, HJ Möller, B Bondy Neuroscience 159 (4), 1274-1282, 2009 | 50 | 2009 |
| Differential melatonin alterations in cerebrospinal fluid and serum of patients with major depressive disorder and bipolar disorder JM Bumb, F Enning, JK Mueller, T van der List, C Rohleder, P Findeisen, ... Comprehensive psychiatry 68, 34-39, 2016 | 48 | 2016 |
| Familial abnormalities of endocannabinoid signaling in schizophrenia D Koethe, F Pahlisch, M Hellmich, C Rohleder, JK Mueller, ... The World Journal of Biological Psychiatry 20 (2), 117-125, 2019 | 43 | 2019 |
| Association of anandamide with altered binocular depth inversion illusion in schizophrenia AR Reuter, JM Bumb, JK Mueller, C Rohleder, F Pahlisch, F Hanke, ... The World Journal of Biological Psychiatry 18 (6), 483-488, 2017 | 34 | 2017 |
| Effects of cannabidiol and delta-9-tetrahydrocannabinol on emotion, cognition, and attention: a Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy … T Woelfl, C Rohleder, JK Mueller, B Lange, A Reuter, AM Schmidt, ... Frontiers in psychiatry, 1220, 2020 | 31 | 2020 |
| Neural autoantibodies in cerebrospinal fluid and serum in clinical high risk for psychosis, first-episode psychosis, and healthy volunteers CG Bien, C Rohleder, JK Mueller, CI Bien, D Koethe, FM Leweke Frontiers in psychiatry 12, 382, 2021 | 25 | 2021 |
| Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence? JK Mueller, P Riederer, WE Müller Pharmacopsychiatry 55 (01), 7-15, 2022 | 15 | 2022 |
| Changes in the pattern of suicides and suicide attempt admissions in relation to the COVID-19 pandemic C Reif-Leonhard, D Lemke, F Holz, KF Ahrens, C Fehr, M Steffens, ... European archives of psychiatry and clinical neuroscience, 1-9, 2022 | 10 | 2022 |
| The endocannabinoid system as a pharmacological target for antipsychotic treatment and more? C Rohleder, F Pahlisch, C Schaefer, M Hellmich, F Enning, ... EARLY INTERVENTION IN PSYCHIATRY 6, 7-7, 2012 | 7 | 2012 |
| Pharmakologie von cannabis und cannabinoiden C Rohleder, J Müller Psychopharmakotherapie 27, 105-113, 2020 | 4 | 2020 |
| What is the promise of nicotinergic compounds in schizophrenia treatment? JK Mueller, C Rohleder, FM Leweke Future Medicinal Chemistry 8 (17), 2009-2012, 2016 | 4 | 2016 |
| Basic data for bipolar disorders: genetics, neurobiology and pharmacology. WE Müller, JK Müller Medizinische Monatsschrift fur Pharmazeuten 39 (9), 371-376, 2016 | 4 | 2016 |
| Endocannabinoids and Neuropeptides in CSF and Serum from Borderline Personality Disorder Patients D Koethe, E Schwarz, C Schaefer, F Enning, JK Mueller, JM Bumb, ... Biological Psychiatry 75 (9), 148S-148S, 2014 | 4 | 2014 |
